Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q4 EPS of ($0.50), $0.01 worse than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.